Imperial Collage Healthcare


Test Background
Digoxin is administered for the treatment of heart failure in addition to supraventricular arrhythmias (particularly atrial fibrillation and atrial flutter).

Clinical Indications
Therapeutic drug monitoring Suspected toxicity caution: low potassium (diuretics), thyroid disease, renal impairment or recent myocardial infarction. Contraindicated in hypertrophic cardiomyopathy, intermittent heart-block, ventricular tachycardia

Reference Range
Normal: 0.5-2.0 μg/L Target range in heart failure: 0.5-1.0 μg/L

Sample Required
SST (gold top)

Sample Collection

Take blood 6 hours post dose

Sample Volume
0.5 mL

Turnaround Time
1 day

Filter by A-Z

Select a test from the left to view more details.